188.68
price up icon3.40%   6.20
after-market 시간 외 거래: 177.58 -11.10 -5.88%
loading
전일 마감가:
$182.48
열려 있는:
$180.89
하루 거래량:
990.33K
Relative Volume:
1.34
시가총액:
$10.63B
수익:
$4.08B
순이익/손실:
$431.79M
주가수익비율:
20.01
EPS:
9.43
순현금흐름:
$486.92M
1주 성능:
+2.54%
1개월 성능:
-1.08%
6개월 성능:
-19.18%
1년 성능:
+3.72%
1일 변동 폭
Value
$180.50
$189.18
1주일 범위
Value
$176.48
$189.18
52주 변동 폭
Value
$166.87
$275.00

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
명칭
Charles River Laboratories International Inc
Name
전화
781-222-6000
Name
주소
251 BALLARDVALE ST, WILMINGTON, MA
Name
직원
0
Name
트위터
@criverlabs
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
CRL's Discussions on Twitter

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-02-15 다운그레이드 Guggenheim Buy → Neutral
2023-09-13 개시 TD Cowen Market Perform
2023-07-10 다운그레이드 Citigroup Buy → Neutral
2023-02-23 업그레이드 Guggenheim Neutral → Buy
2023-01-12 다운그레이드 Jefferies Buy → Hold
2022-09-30 업그레이드 Jefferies Hold → Buy
2022-08-25 개시 Credit Suisse Outperform
2022-08-04 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-05-24 개시 Guggenheim Neutral
2022-04-25 다운그레이드 Jefferies Buy → Hold
2022-04-07 개시 Stephens Overweight
2022-02-17 재확인 BofA Securities Buy
2022-02-17 업그레이드 Citigroup Neutral → Buy
2022-02-17 재확인 Deutsche Bank Buy
2022-02-17 재확인 Morgan Stanley Overweight
2022-02-17 재확인 UBS Buy
2021-08-05 재개 Credit Suisse Neutral
2020-12-16 다운그레이드 Citigroup Buy → Neutral
2020-09-10 업그레이드 Jefferies Hold → Buy
2020-07-01 업그레이드 BofA Securities Neutral → Buy
2020-05-13 업그레이드 UBS Neutral → Buy
2020-04-21 다운그레이드 Jefferies Buy → Hold
2020-03-27 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-03-02 개시 Deutsche Bank Buy
2020-02-18 업그레이드 Wolfe Research Peer Perform → Outperform
2020-01-10 업그레이드 Goldman Neutral → Buy
2020-01-08 개시 Wells Fargo Overweight
2020-01-07 개시 Citigroup Buy
2019-10-18 다운그레이드 BofA/Merrill Buy → Neutral
2019-06-10 개시 SVB Leerink Outperform
2019-04-30 재개 Evercore ISI Outperform
2018-12-14 개시 Deutsche Bank Buy
2018-10-09 개시 UBS Neutral
2018-08-23 업그레이드 Raymond James Mkt Perform → Outperform
2018-07-17 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2018-06-15 업그레이드 KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 업그레이드 SunTrust Hold → Buy
모두보기

Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스

pulisher
11:37 AM

Charles River Laboratories Q3 2024 Earnings Preview - MSN

11:37 AM
pulisher
04:13 AM

Stephens Inc. AR Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

04:13 AM
pulisher
03:55 AM

Cell Banking Outsourcing Market Report: Detailed Insights - openPR

03:55 AM
pulisher
Nov 04, 2024

Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

abrdn plc Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Gmp Cell Banking Services Market Size, Share, and Forecast - openPR

Nov 04, 2024
pulisher
Nov 03, 2024

Restructuring update likely in Charles River Labs’ Q3 earnings - The Business Journals

Nov 03, 2024
pulisher
Nov 01, 2024

Charles River Laboratories International, Inc. (NYSE:CRL) Short Interest Update - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 31, 2024

Zacks Research Has Weak Forecast for CRL FY2024 Earnings - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Congress Asset Management Co. Sells 9,239 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

WD Rutherford LLC Has $338,000 Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Charles River Laboratories International (CRL) to Release Earnings on Wednesday - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Charles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Reduce" by Analysts - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Fragment Based Drug Discovery Market Size Projected to Achieve USD 2.1 Billion by 2031, Expanding at a 11.5% CAGR | Analysis by Transparency Market Research, Inc. - GlobeNewswire Inc.

Oct 29, 2024
pulisher
Oct 29, 2024

Why Charles River (CRL) is Poised to Beat Earnings Estimates Again - Zacks Investment Research

Oct 29, 2024
pulisher
Oct 28, 2024

The Latest Breaking News from Charles River Laboratories - Inkl

Oct 28, 2024
pulisher
Oct 28, 2024

Charles River Laboratories' Q3 2024 Earnings: What to Expect - TradingView

Oct 28, 2024
pulisher
Oct 28, 2024

Charles River Laboratories' Q3 2024 Earnings: What To Expect - Barchart

Oct 28, 2024
pulisher
Oct 28, 2024

Assenagon Asset Management S.A. Acquires 29,621 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

Ophthalmic Clinical Trials Market Intelligence Reports - openPR

Oct 27, 2024
pulisher
Oct 27, 2024

Boston Trust Walden Corp Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Oct 27, 2024
pulisher
Oct 26, 2024

Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet - Simply Wall St

Oct 26, 2024
pulisher
Oct 25, 2024

Dumont & Blake Investment Advisors LLC Sells 4,360 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Oct 25, 2024
pulisher
Oct 23, 2024

CLSA Begins Coverage on Charles River Laboratories International (NYSE:CRL) - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

Charles River Laboratories International (NYSE:CRL) Trading Down 4.9%Should You Sell? - MarketBeat

Oct 22, 2024
pulisher
Oct 22, 2024

Charles River Laboratories International Inc (CRL) Shares Down 3 - GuruFocus.com

Oct 22, 2024
pulisher
Oct 22, 2024

CRL Gears Up for Q3 Earnings: Here's What You Need to Know - Yahoo Finance

Oct 22, 2024
pulisher
Oct 21, 2024

Charles River Launches Retrogenix Non-Human Protein Library - Contract Pharma

Oct 21, 2024
pulisher
Oct 21, 2024

FibroBiologics and Charles River link for chronic disease therapies manufacture - Yahoo News

Oct 21, 2024
pulisher
Oct 20, 2024

Allspring Global Investments Holdings LLC Acquires 509,163 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Oct 20, 2024
pulisher
Oct 18, 2024

CRL Stock Gains From New Retrogenix Non-Human Protein Library Launch - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

Research Analysts Set Expectations for CRL Q3 Earnings - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Charles River Laboratories International, Inc. (NYSE:CRL) Stock Position Decreased by SG Americas Securities LLC - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Genetic Toxicology Testing Market to See Booming Growth - openPR

Oct 18, 2024
pulisher
Oct 17, 2024

Charles River Launches New Retrogenix® Non-Human Protein Library - sharewise

Oct 17, 2024
pulisher
Oct 17, 2024

December 20th Options Now Available For Charles River Laboratories International (CRL) - Nasdaq

Oct 17, 2024
pulisher
Oct 17, 2024

Charles River Launches Non-Human Protein Library - Baystreet.ca

Oct 17, 2024
pulisher
Oct 16, 2024

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call - sharewise

Oct 16, 2024
pulisher
Oct 16, 2024

CRLCharles River Laboratories International, Inc. Latest Stock News & Market Updates - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

meQuilibrium Honors JPMorganChase, Dow Chemical, Liberty Mutual Insurance, Leidos, KBR, Charles River Labs, Point32 Health, and Qurate Retail Group for Achievements in Supporting Employee Resilience - PR Newswire

Oct 16, 2024
pulisher
Oct 16, 2024

Charles River Laboratories International (NYSE:CRL) Upgraded to Buy by StockNews.com - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Cellular and Gene Therapy CDMO Market Year 2034|Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM – IndiaPolitics.com - IndiaPolitics.com

Oct 16, 2024
pulisher
Oct 15, 2024

Cell Banking System Market Demand With Future Forecast – WuXi AppTec, Charles River Laboratories International, Eurofins Scientific, Merck KGaA – Cauverynews - Cauverynews

Oct 15, 2024
pulisher
Oct 14, 2024

Charles River Labs stock under pressure amid COVID backlog normalization By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

Charles River Labs stock under pressure amid COVID backlog normalization - Investing.com India

Oct 14, 2024
pulisher
Oct 14, 2024

Charles River Laboratories International (NYSE:CRL) Receives New Coverage from Analysts at Redburn Atlantic - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Clinical Trials Market 2024-2031: Global Industry Size, Share, - openPR

Oct 14, 2024
pulisher
Oct 14, 2024

Cell Banking Outsourcing Market Size, Share, and Forecast - openPR

Oct 14, 2024

Charles River Laboratories International Inc (CRL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
자본화:     |  볼륨(24시간):